BackSigilon Therapeutics Overview

Sigilon Therapeutics Operating Income

Operating Income for SGTX.

Quarterly Operating Income

$-7435000.00
↓ 47.03% YoY

As of Jun 30, 2023

Annual Operating Income (TTM)

$-30835000.00
↓ 52.23% YoY

Trailing 12 months ending Jun 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin